BACKGROUND: Thr300Ala polymorphism in ATG16L1 was reported as a susceptibility factor to Crohn's disease (CD). Inconsistently replicated associations with ulcerative colitis (UC) and specifically with ileal CD were also reported. Our aims were: to replicate the ATG16L1 Thr300Ala association with inflammatory bowel disease (IBD) in the Spanish population, to perform a meta-analysis to determine the risk conferred to the different IBD subgroups, and to test for the interaction with CARD15 or IL23R risk loci. METHODS: Thr300Ala (rs2241880) single nucleotide polymorphism (SNP) was genotyped in 712 IBD patients and 745 controls by TaqMan technology. Genetic frequencies were compared with chi-square tests. Our findings were pooled in a meta-analysis. RESULTS: In Spain, we observed an association of rs2241880 with CD (P = 0.008; odds ratio [OR, 95% confidence interval, CI] = 1.28 [1.06-1.54]), but not with UC. No significant differences emerged when patients were stratified by clinical features. Similarly, the meta-analysis demonstrated a significant association only with CD (P < 10(-4); OR [95% CI] = 1.33 [1.28-1.38]). A significant difference between ileal CD patients and controls was observed, but heterogeneity was found in comparisons involving colonic CD patients and definite conclusions cannot be drawn. No interaction between rs2241880 and the established CARD15 or IL23R susceptibility variants was observed. CONCLUSIONS: The Thr300Ala polymorphism is associated with CD, regardless of the CARD15 or IL23R status, but not with UC. Stratification by clinical phenotypes did not show definitive results because of the existing heterogeneity among studies.
BACKGROUND: Thr300Ala polymorphism in ATG16L1 was reported as a susceptibility factor to Crohn's disease (CD). Inconsistently replicated associations with ulcerative colitis (UC) and specifically with ileal CD were also reported. Our aims were: to replicate the ATG16L1 Thr300Ala association with inflammatory bowel disease (IBD) in the Spanish population, to perform a meta-analysis to determine the risk conferred to the different IBD subgroups, and to test for the interaction with CARD15 or IL23R risk loci. METHODS: Thr300Ala (rs2241880) single nucleotide polymorphism (SNP) was genotyped in 712 IBD patients and 745 controls by TaqMan technology. Genetic frequencies were compared with chi-square tests. Our findings were pooled in a meta-analysis. RESULTS: In Spain, we observed an association of rs2241880 with CD (P = 0.008; odds ratio [OR, 95% confidence interval, CI] = 1.28 [1.06-1.54]), but not with UC. No significant differences emerged when patients were stratified by clinical features. Similarly, the meta-analysis demonstrated a significant association only with CD (P < 10(-4); OR [95% CI] = 1.33 [1.28-1.38]). A significant difference between ileal CDpatients and controls was observed, but heterogeneity was found in comparisons involving colonic CDpatients and definite conclusions cannot be drawn. No interaction between rs2241880 and the established CARD15 or IL23R susceptibility variants was observed. CONCLUSIONS: The Thr300Ala polymorphism is associated with CD, regardless of the CARD15 or IL23R status, but not with UC. Stratification by clinical phenotypes did not show definitive results because of the existing heterogeneity among studies.
Authors: Hongyan Chen; Alexander Lee; Anne Bowcock; Wei Zhu; Ellen Li; Matthew Ciorba; Steven Hunt Journal: Dis Colon Rectum Date: 2011-08 Impact factor: 4.585
Authors: Kathrin Buffen; Marije Oosting; Svenja Mennens; Paras K Anand; Theo S Plantinga; Patrick Sturm; Frank L van de Veerdonk; Jos W M van der Meer; Ramnik J Xavier; Thirumala-Devi Kanneganti; Mihai G Netea; Leo A B Joosten Journal: J Biol Chem Date: 2013-02-05 Impact factor: 5.157
Authors: Tania O Crişan; Theo S Plantinga; Frank L van de Veerdonk; Marius F Farcaş; Monique Stoffels; Bart-Jan Kullberg; Jos W M van der Meer; Leo A B Joosten; Mihai G Netea Journal: PLoS One Date: 2011-04-07 Impact factor: 3.240
Authors: Inga Peter; Adele A Mitchell; Laurie Ozelius; Monica Erazo; Jianzhong Hu; Dana Doheny; Maria T Abreu; Daniel H Present; Thomas Ullman; Keith Benkov; Burton I Korelitz; Lloyd Mayer; Robert J Desnick Journal: BMC Med Genet Date: 2011-05-06 Impact factor: 2.103
Authors: John Janez Miklavcic; Kareena Leanne Schnabl; Vera Christine Mazurak; Alan Bryan Robert Thomson; Michael Thomas Clandinin Journal: J Nutr Metab Date: 2012-02-12